English 
French 
Biolab & Co.
We are Biolab & Co., a Brazilian pharmaceutical group that integrates science, innovation and industry to develop therapeutic solutions that promote health and quality of life. Operating in human health, veterinary health and animal nutrition, we are part of the Brazilian pharmaceutical industry and are driven by knowledge, collaboration and a commitment to ethics, purpose and integrity. The group brings together six brands and a portfolio of over 500 products, structured in the business units Biolab Farmacêutica, Biolab Genéricos, Avert Saúde Humana, Avert Biolab Saúde Animal, Exzell Pharma and Pet Nutrition.
With a vision of being a benchmark among Brazilian pharmaceutical groups, we continually invest in research, development and innovation. The company has production units in São Paulo and Minas Gerais, as well as Research, Development and Innovation (RD&I) centers in Brazil and Canada. With more than 50 international partnerships and more than 400 patent applications, we have strengthened its innovation and global expansion strategy.
We believe that promoting responsible environmental practices within the pharmaceutical industry is essential to the well-being of both the planet and the communities we serve. Our commitment is ongoing and reflects the vision of a company that understands its role in driving the transformation toward a more sustainable future.
With a mission to bring innovative products from around the world to the Canadian market, Exzell Pharma aims to provide new and effective therapeutic options to patients in areas of unmet need.
After being incorporated into Biolab in 2022, the possibilities and motivation for Exzell Pharma have increased even more to become a leading source of safe, effective and affordable healthcare products in Canada.
The acquisition of Exzell Pharma represents a major growth opportunity for both the Brazilian and Canadian markets, through the expansion of the product portfolio. The purchase of Exzell Pharma also offers a significant growth opportunity for the Biolab group, by establishing an international export platform from Canada.
Biolab’s mission to enhance well-being is supported by its expanding international presence and collaborative approach to healthcare. With a team of over 4,000 professionals and one of the largest sales forces in Brazil, Biolab fosters strong relationships with healthcare providers, conducting more than 320,000 visits annually. This extensive network underscores Biolab’s experience and solidifies its position as a trusted partner in healthcare, advancing solutions to meet patients’ evolving needs.
As part of the Biolab & Co. , Exzell Pharma benefits from the expertise, resources, and strategic vision of this dynamic organization. This collaboration enables Exzell, a proudly Canadian company, to expand its healthcare offerings across Canada, focusing on both human and animal health. With Biolab’s trust in the Canadian market and its support, Exzell is well-positioned to forge new partnerships and develop innovative products that improve quality of life and promote better health outcomes across borders.